News About: Pharm. Industry
Daewoong Pharmaceutical challenges to make KRW 500 billion sales per a year in the Chinese marketDaewoong Pharmaceutical has made an ambitious plan to reach KRW 500 billion sales by 2020 in the Chinese market.
According to Daewoong Pharmaceutical, starting with the launch ...
|
The hottest products in Olive Young are... ‘Beauty over Healthcare products’
Claiming to be a drug store, Olive Young had a step forward towards a ‘health and beauty store’ from a ‘drug store.’
Among the products sold by the largest health and beauty (H&B) store, Olive Young, sales of beauty ...
The Korean antibiotics market hascreated 777 products for the past 40 years… United Pharma made the most with 42 products
It is observed that the number of antibiotics approved in Korea has reached 777 products for the past 40 years, and Korea United Pharm is owning the most with 42 products.
Starting with 4 products, such as ‘Tamoxen T...
Facing the patent expiration of Celebrex, the pharmaceutical industry is being active to get generic approvals
Generics of the nonsteroidal type anti-inflammatoryanalgesic drug, Celebrex (generic name: celecoxib), are preparing to launch in the market as its patent expiration is coming soon in this June.
According to the week...
What is the reason for active transfers of salesmen in pharmaceutical companies?
Due to the reinforcement on pharmaceutical rebate restriction, it is known that salesmen of the top pharmaceutical companies are actively transferring to mid-sized companies.
According to the pharmaceutical industry,...
Despite the slump of large drugs, products of multinational pharmaceutical companies swept the market
Despite the slump of large drugs, it is confirmed that most products positioning inthe toptier with prescription expenses are products of multinational pharmaceutical companies.
According to the Medipana News’s analy...
What is the market appearance between top vs. mid-sized and domestic vs. multinational pharmaceutical companies?
Last year, it is observed that mid-sized and domestic pharmaceutical companies were relativelysuperior to top and multinational companies, respectively. Compared to the year before, market shares of mid-sized and dome...
The medical industry is asking for the public help against the Regulation Guillotine… also started on the Nationwide Public Sentiment
In order to blockthe object of the government’s ‘Regulation Guillotine’, including the use of modern medical equipment for oriental doctors, the Korean Medical Association (KMA) will start the Nationwide Public Sentim...
Green Cross received a KRW 81 billion order of varicella vaccines
Last year, Green Cross, that recorded KRW 200 million exports for the first time in the domestic pharmaceutical industry,made a splendid achievement to export the largest amount of varicella vaccines to an internation...
What is the reason to delay launching the SGLT-2 inhibitor type diabetes treatment?
Boehringer Ingelheim and Lilly decided to delay launching the diabetes treatment ‘Jardiance’ in the market.
According to the industry concerned on the 15th, Boehringer Ingelheim and Lilly (hereinafter referring to BI...
